Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193805-13-001600
Filing Date
2013-09-16
Accepted
2013-09-13 19:12:38
Documents
11
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 e611283_10ka-retrophin.htm 10-K/A 683050
2 e611283_ex31-1.htm EX-31.1 14555
3 e611283_ex31-2.htm EX-31.2 14841
4 e611283_ex32-1.htm EX-32.1 5727
5 e611283_ex32-2.htm EX-32.2 5781
  Complete submission text file 0001193805-13-001600.txt   4093011

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rtrx-20121231.xml EX-101.INS 326681
7 XBRL TAXONOMY EXTENSION SCHEMA rtrx-20121231.xsd EX-101.SCH 31271
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rtrx-20121231_cal.xml EX-101.CAL 34255
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rtrx-20121231_def.xml EX-101.DEF 39466
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rtrx-20121231_lab.xml EX-101.LAB 181886
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rtrx-20121231_pre.xml EX-101.PRE 130141
Mailing Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017
Business Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017 212-983-1310
Retrophin, Inc. (Filer) CIK: 0001438533 (see all company filings)

EIN.: 262383102 | State of Incorp.: OK | Fiscal Year End: 0229
Type: 10-K/A | Act: 34 | File No.: 000-53293 | Film No.: 131097405
SIC: 2834 Pharmaceutical Preparations